|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61P 29/00 | |
| A61P 3/00 | |||
| A61K 38/17 | |||
| A61L 31/16 | |||
| A61K 9/06 | |||
| A61L 27/00 | |||
| A61K 38/07 |
| (11) | Patento numeris | 2504035 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10830687.9 |
| Europos patento paraiškos padavimo data | 2010-11-10 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-10-03 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-03-27 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2010/056277 |
| Data | 2010-11-10 |
| (87) | Numeris | WO 2011/060104 |
| Data | 2011-05-19 |
| (30) | Numeris | Data | Šalis |
| 25974809 P | 2009-11-10 | US |
| (72) |
MACKEL, Michael, John, US
PARK, John, US
|
| (73) |
Allegro Pharmaceuticals, LLC,
31103 Rancho Viejo Road, No. 2249, San Juan Capistrano, CA 92675,
US
|
| (54) | COMPOSITIONS AND METHODS FOR INHIBITING CELLULAR ADHESION OR DIRECTING DIAGNOSTIC OR THERAPEUTIC AGENTS TO RGD BINDING SITES |
| COMPOSITIONS AND METHODS FOR INHIBITING CELLULAR ADHESION OR DIRECTING DIAGNOSTIC OR THERAPEUTIC AGENTS TO RGD BINDING SITES |